A preliminary study of protoporphyrin-IX as a potential candidate for identification of lung cancer cells using fluorescence microscopy

Photodiagnosis and Photodynamic Therapy

Volumn 6, Issue 3-4, 2009, Pages 221-226

  Hyun, Dae Sung ^a   Kim, Hong Tae ^a   Jheon, Sang Hoon ^b   Park, Seung Il ^c   Kim, Jong Ki ^a  

^a Catholic University of Daegu   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

Fluorescence sputum cytology; Lung cancer cell; Population screening; Protoporphyrin IX

Indexed keywords

PROTOPORPHYRIN;

ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; CULTURE MEDIUM; EARLY CANCER; FLUORESCENCE MICROSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG PARENCHYMA; PRIORITY JOURNAL; SPUTUM ANALYSIS;

FLUORESCENT DYES; HUMANS; LUNG NEOPLASMS; MICROSCOPY, FLUORESCENCE; PROTOPORPHYRINS;

EID: 70449685562     PISSN: 15721000     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2009.10.004     Document Type: Article

References (26)

1. The International Early lung cancer Action Program (ELCAP). Survival of patients with stage I lung cancer detected on CT screening. New Eng J of Med 355 (2006) 1763-1771
2. Moghissi K., Dixon K., Thorpe J.A.C., Stringer M., and Oxtoby C. Photodynamic therapy (PDT) in early central lung cancer: a treatment option for patients ineligible for surgical resection. Thorax 62 (2007) 391-395
3. Ost D, Photodynamic therapy in lung cancer: a review in lung cancer. In: Driscoll B, editor. Diagnostic and therapeutic methods, vol. 2, Methods Mol Med 75; 2002, 507-526.
4. Cavaliere S., Foccoli P., Toninelli C., and Feijo S. Nd:YAG laser therapy in lung cancer: an 11 year experience with 2253 application in 1585 patients. J Bronchol 1 (1994) 105-111
5. Van Boxem T.J., Venmans B.J., Schramel F.M., et al. Radiographically occult lung cancer treated with fiberoptic bronchoscopic electrocautery: a pilot study of a simple and inexpernsive technique. Eur Respir J 11 (1998) 169-172
6. Hirsch F.R., Franklin W.A., Gasdar A.F., and Bunn P.A. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res 7 (2001) 5-22
7. Russo P., Paleari L., Granone P., Cesario A., and Pastorino U. Computed tomography screening for lung cancer in a high-risk population: update on current status. J Natl Cancer Inst 100 (2008) 1043-1044
8. Yee J., Sadar M.D., Sin D.D., et al. Connective tissue-activating peptide III: a novel blood biomarker for early lung cancer detection. J Clin Oncol 27 (2009) 2787-2792
9. Matthew B., Stanbrook M.B., and Flegel K. A pause for thought on lung cancer screening. Can Med Assoc J 180 (2009) 793-1793
10. Kennedy T.C., and Prindiville S. Screening for lung cancer revisited and the role of sputum cytology and fluorescence bronchoscopy in a high-risk group. Chest 117 (2000) 72S-79S
11. Lam B., Lam S.Y., Wong M.P., et al. Sputum cytology examination followed by autofluorescence bronchoscopy: a practical way of identifying early stage lung cancer in central airway. Lung Cancer 4 (2009) 289-294
12. Gazdar A.F., and Minna J.D. Molecular detection of early lung cancer. J Natl Cancer Inst 91 (1999) 299-301
13. van den Bergh H. Early detection of lung cancer and the role of endoscopic fluorescence imaging. Med Laser Appl 18 (2003) 20-26
14. Häuβinger K., Becker H., Stanzel F., et al. Autofluorescence bronchoscopy with white light bronchoscopy compared with white light bronchoscopy alone for the detection of precancerous lesions: a European randomised controlled multicentre trial. Thorax 60 (2005) 496-503
15. Lee P., van den Berg R.M., Lam S., et al. Color fluorescence ratio for detection of bronchial dysplasia and carcinoma in situ. Clin Cancer Res 15 (2009) 4700-4705
16. Steven F.S., Payne P.W., Palcic B., Katsumi T., and Kato H. Fluorescent location of lung tumour cells. Anticancer Res 18 (1998) 3323-3326
17. Steven F.S., Payne P.W., and Palcic B. Fluorescent location of malignant cells in smears obtained from sputum. Anticancer Res 14 (1994) 2021-2024
18. Steven F.S., Payne P.W., Palcic B., and Katsumi T. Sputum cells from lung tumor patients carry a cell surface marker not found in normal sputum. Anticancer Res 18 (1998) 3855-3858
19. Cortese D.A. Hematoporphyrin derivative in the detection and localization of radiographically occult lung cancer. Rev Respir Dis 126 (1982) 1087-1099
20. Kato H. Early detection of lung cancer by means of hematoporphyrin derivative fluorescence and laser photoradiation. Clin Chest Med 6 (1985) 237-248
21. Patel K.B. In: Doiron D., and Gomer C. (Eds). Fluorescing cells in sputum after parenteral HPD, porphyrin localization and treatment of tumors. Prog Clin Biol Res 170 (1984) 521-530
22. University of Colorado at Denver and Health Sciences Center. Sputum cytology in screening heavy smokers for lung cancer, 2009 http://clinicaltrials.gov/ct2/show/NCT00103363.
23. Hautmann H., Pichler J.P., Stepp H., Baumgartner R., Gamarra F., and Huber R.M. In-vivo kinetics of inhaled 5-aminolevulinic acid-induced protoporphyrin IX fluorescence in bronchial tissue. Resp Res 8 (2007) 33
24. Piotrowski W.J., Marczak J., Nawrocka A., Antczak A., and Gorski P. Inhalationsof 5-ALA in photodynamic diagnosis of bronchial cancer. Monaldi Arch Chest Dis 61 (2004) 86-93
25. Huber R.M., Gamarra F., Hautmann H., Haubinger K., Wagner S., Castro M., and Baumgartner R. 5-Aminolaevulinic acid for the fluorescence detection of bronchial tumors. Diag Therap Endosc 5 (1999) 113-118
26. Leonhard M. New incoherent autofluorescence/fluorescence system for early detection of lung cancer. Diag Therap Endosc 5 (1999) 71-75